Therapeutic Antibodies Get to Know the Magic Bullet
Therapeutic antibodies have been in unprecedented success and the success will be continuing. Its growth in research and revenues, and recognition of their potential has made them a focus. It seems to be the real "magic bullet" that has largely been realized.
An overview of therapeutic antibodies
As early as in 1970s, the emergence of monoclonal antibodies has been thought as ideal reagents for imaging and therapies. With improved specificity and affinity on molecules, expectation people hold on them was expanded to be used as targeting reagents. However, until 1990s, the development of molecular biology, such as recombinant antibodies, cloning, random or directed mutagenesis has made them possible to be used more properly.
According to revenue statistics from several top therapeutic antibodies providers, the figure has showed that therapeutic antibodies take up a majority of the recent pharmaceutical sales. In addition to money drive, the research and development in the field has been increasing over the past several years and is expected to grow with new generations in the rapidly growing therapeutic market segment.
And these day antibody therapeutics are an alternative treatment choice for some autoimmune, oncological conditions, combination therapies and cell engineering due to their high specificity and sensitivity.
As a result, many biotechnology companies aim to advance the commercial process of such a diverse array of antibody therapeutics. The new enthusiasm brought by them has lighted a positive spirit within the industry with regard to the discovery and commercialization of "next-generation" antibodies.
Therapeutic antibodies at Creative Diagnostics—superior against tough targets
The production of therapeutic antibodies and conjugations is one of the fastest growing sectors of the pharmaceutical industry. But the constant accuracy and consistency over the course of bioprocessing can raise challenges. With the help of technological advances and profound understanding of therapeutic antibodies mechanism of action, Creative Diagnostics scientists have gained breakthroughs in some essential areas to improve them.
From the very first discovery to the most recent ground-breaking therapeutic conditions, Creative Diagnostics leads the way in providing and partnering with biopharmaceutical companies with improved efficiency and safety: better targets, better linkers, and better toxins.
At Creative Diagnostics, we have more than hundreds of therapeutic antibodies in development for cancer, immunology, etc., by utilizing the molecular engineering techniques, and we made mind continuing to explore the vital areas of research.
See our hot products:
Anti-human egfr therapeutic antibody (erbitux)
Anti-human tnf therapeutic antibody (remicade)
Anti-human cd20 therapeutic antibody (mabthera)
Anti-human vegf therapeutic antibody (avastin)
Anti-human tnf therapeutic antibody (humira)
And more…
Post Your Ad Here
Comments